SLGL
Sol Gel Technologies LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$252.16M
P/E Ratio
—
EPS
$-2.28
Beta
1.17
52W High
$97.97
52W Low
$6.57
50-Day MA
$79.08
200-Day MA
$48.19
Dividend Yield
—
Profit Margin
-31.60%
Forward P/E
9.34
PEG Ratio
—
About Sol Gel Technologies Ltd
Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological pharmaceuticals based on its Israel-patented microencapsulation delivery system. The company is headquartered in Ness Ziona, Israel.
Fundamentals
| Revenue (TTM) | $19.39M |
| Gross Profit (TTM) | $-3.42M |
| EBITDA | $-7.48M |
| Operating Margin | -497.90% |
| Return on Equity | -23.70% |
| Return on Assets | -14.40% |
| Revenue/Share (TTM) | $6.96 |
| Book Value | $8.19 |
| Price-to-Book | 10.76 |
| Price-to-Sales (TTM) | 13.01 |
| EV/Revenue | 11.47 |
| EV/EBITDA | 0.23 |
| Quarterly Earnings Growth (YoY) | 487.60% |
| Quarterly Revenue Growth (YoY) | 150.40% |
| Shares Outstanding | $3.25M |
| Float | 699,130 |
| % Insiders | 60.14% |
| % Institutions | 35.30% |
Historical Volatility
HV 10-Day
71.13%
HV 20-Day
68.17%
HV 30-Day
107.38%
HV 60-Day
108.91%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026